Get Support
+880-02-9337667SOMATEC PHARMACEUTICALS LTD. is a fast growing pharmaceutical company in Bangladesh.
28/B, Segun Bagicha, Dhaka-1000, Bangladesh.
+880-02-9337667
+880-02-9357827
+880-02-8391480
info@somatecpharmabd.com
Neoprox (Cefpodoxime Proxetil) is indicated for the treatment of patients infected with susceptible strains of microorganisms, which include a wide range of gram-positive & gram-negative bacteria. As it is highly stable in presence of b-lactamase enzyme, it is more effective against gram-positive bacteria than other 3rd generation oral Cephalosporins.
Neoprox (Cefpodoxime Proxetil) is indicated in the following diseases: -
1. Lower respiratory tract infections: Acute community-acquired pneumonia, acute
bacterial exacerbation of chronic bronchitis.
2. Upper respiratory tract infections: Acute otitis media, acute maxillary sinusitis,
pharyngitis, tonsillitis.
3. Sexually transmitted diseases: Acute uncomplicated urethral & cervical
gonorrhea, acute ano-rectal infection in woman caused by N. gonorrhea.
4. Uncomplicated urinary tract infections: Cystitis, pyuria.
5. Skin & soft tissue infections: Furuncle, cellulitis, subcutaneous abscess,
Infectious atheroma & periproctal abscess.
Children:
15 days - 6 months: 4 mg/kg every 12 hours
6 months - 2 years : 40 mg every 12 hours
3 - 8 years : 80 mg every 12 hours
Over 9 years : 100 mg every 12 hours
Patients with liver cirrhosis: Cefpodoxime proextil's pharmacokinetics in cirrhotic patients is similar to those in healthy subjects. Dose adjustment is not necessary in this population.
Antacids: Concomitant administrations of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 -blockers reduces plasma level by 24% to 42% and the extent of absorption by 27% to 32% respectively.
Probenecid: Renal excretion of Cefpodoxime was inhibited by probenecid and resulted in an approximately 31% increase in AUC.
Nephrotoxic drugs: Close monitoring of renal function advised when Cefpodoxime proxetil is administered concomitantly with compounds of known nephrotoxic potential.
Cefpodoxime proxetil is contraindicated in patients with a known allergy to Cefpodoxime or to the cephalosporin group of antibiotics.
Cefpodoxime has very few side effects. The side effects include diarrhoea, nausea, skin & vaginal fungal infection, abdominal pain, headache, chest pain, myalgia, dyspepsia, dizziness, vertigo, cough etc. In children, incidence of fungal skin rash is more than adults.
Cefpodoxime was neither teratogenic nor embryocidal in animal trial. There is, however, no adequate and well-controlled study of cefpodoxime proxetil in pregnant woman. The drug should be used during pregnancy only if clearly needed.
In patients with transient or persistent reduction in urinary output due to renal insufficiency, the total daily dose of cefpodoxime proxetil should be reduced. As with other broad-spectrum antibiotics, prolonged use of cefpodoxime proxetil may result in overgrowth of non-susceptible organisms. Repeated evaluation of the patient's condition is essential.
Overdosage may cause toxic reaction. Toxic symptoms include nausea, vomiting, epigastric distress and diarrhea.
Neoprox (Cefpodoxime Proxetil) is indicated for the treatment of patients infected with susceptible strains of microorganisms, which include a wide range of gram-positive & gram-negative bacteria. As it is highly stable in presence of b-lactamase enzyme, it is more effective against gram-positive bacteria than other 3rd generation oral Cephalosporins.
Neoprox (Cefpodoxime Proxetil) is indicated in the following diseases: -
1. Lower respiratory tract infections: Acute community-acquired pneumonia, acute
bacterial exacerbation of chronic bronchitis.
2. Upper respiratory tract infections: Acute otitis media, acute maxillary sinusitis,
pharyngitis, tonsillitis.
3. Sexually transmitted diseases: Acute uncomplicated urethral & cervical
gonorrhea, acute ano-rectal infection in woman caused by N. gonorrhea.
4. Uncomplicated urinary tract infections: Cystitis, pyuria.
5. Skin & soft tissue infections: Furuncle, cellulitis, subcutaneous abscess,
Infectious atheroma & periproctal abscess.
Children:
15 days - 6 months: 4 mg/kg every 12 hours
6 months - 2 years : 40 mg every 12 hours
3 - 8 years : 80 mg every 12 hours
Over 9 years : 100 mg every 12 hours
Patients with liver cirrhosis: Cefpodoxime proextil's pharmacokinetics in cirrhotic patients is similar to those in healthy subjects. Dose adjustment is not necessary in this population.
Antacids: Concomitant administrations of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 -blockers reduces plasma level by 24% to 42% and the extent of absorption by 27% to 32% respectively.
Probenecid: Renal excretion of Cefpodoxime was inhibited by probenecid and resulted in an approximately 31% increase in AUC.
Nephrotoxic drugs: Close monitoring of renal function advised when Cefpodoxime proxetil is administered concomitantly with compounds of known nephrotoxic potential.
Cefpodoxime proxetil is contraindicated in patients with a known allergy to Cefpodoxime or to the cephalosporin group of antibiotics.
Cefpodoxime has very few side effects. The side effects include diarrhoea, nausea, skin & vaginal fungal infection, abdominal pain, headache, chest pain, myalgia, dyspepsia, dizziness, vertigo, cough etc. In children, incidence of fungal skin rash is more than adults.
Cefpodoxime was neither teratogenic nor embryocidal in animal trial. There is, however, no adequate and well-controlled study of cefpodoxime proxetil in pregnant woman. The drug should be used during pregnancy only if clearly needed.
In patients with transient or persistent reduction in urinary output due to renal insufficiency, the total daily dose of cefpodoxime proxetil should be reduced. As with other broad-spectrum antibiotics, prolonged use of cefpodoxime proxetil may result in overgrowth of non-susceptible organisms. Repeated evaluation of the patient's condition is essential.
Overdosage may cause toxic reaction. Toxic symptoms include nausea, vomiting, epigastric distress and diarrhea.